Evidence map›Paper›PMID 36637211›Full record

ArticleBioinformatics (Oxford, England)2023

Dealing with dimensionality: the application of machine learning to multi-omics data.

Dylan Feldner-Busztin, Panos Firbas Nisantzis, Shelley Jane Edmunds, Gergely Boza, Fernando Racimo, Shyam Gopalakrishnan, Morten Tønsberg Limborg, Leo Lahti, Gonzalo G de Polavieja

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Integrating multi-omics data for next-generation cancer research and precision medicine.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dylan Feldner-BusztinChampalimaud Centre for the Unknown, Champalimaud Foundation, 1400-038 Lisbon, Portugal.ORCID 0000-0002-3984-0125
Panos Firbas NisantzisChampalimaud Centre for the Unknown, Champalimaud Foundation, 1400-038 Lisbon, Portugal.ORCID 0000-0001-8748-2978
Shelley Jane EdmundsCenter for Evolutionary Hologenomics, GLOBE Institute, Faculty of Health and Medical Sciences, University of Copenhagen, 1353 Copenhagen, Denmark.ORCID 0000-0002-5815-4294
Gergely BozaCentre for Ecological Research, 1113 Budapest, Hungary.ORCID 0000-0001-6453-8254
Fernando RacimoFaculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-5025-2607
Shyam GopalakrishnanCenter for Evolutionary Hologenomics, GLOBE Institute, Faculty of Health and Medical Sciences, University of Copenhagen, 1353 Copenhagen, Denmark.ORCID 0000-0002-2004-6810
Morten Tønsberg LimborgCenter for Evolutionary Hologenomics, GLOBE Institute, Faculty of Health and Medical Sciences, University of Copenhagen, 1353 Copenhagen, Denmark.ORCID 0000-0002-7718-6531
Leo LahtiDepartment of Computing, University of Turku, 20014 Turku, Finland.ORCID 0000-0001-5537-637X
Gonzalo G de PolaviejaChampalimaud Centre for the Unknown, Champalimaud Foundation, 1400-038 Lisbon, Portugal.ORCID 0000-0001-5359-3426

Funding

Danish National Research Foundation CEH-DNRF143European Union's Horizon 2020 research and innovation programme
6 · The paper itself

Abstract

motivationMachine learning (ML) methods are motivated by the need to automate information extraction from large datasets in order to support human users in data-driven tasks. This is an attractive approach for integrative joint analysis of vast amounts of omics data produced in next generation sequencing and other -omics assays. A systematic assessment of the current literature can help to identify key trends and potential gaps in methodology and applications. We surveyed the literature on ML multi-omic data integration and quantitatively explored the goals, techniques and data involved in this field. We were particularly interested in examining how researchers use ML to deal with the volume and complexity of these datasets.

resultsOur main finding is that the methods used are those that address the challenges of datasets with few samples and many features. Dimensionality reduction methods are used to reduce the feature count alongside models that can also appropriately handle relatively few samples. Popular techniques include autoencoders, random forests and support vector machines. We also found that the field is heavily influenced by the use of The Cancer Genome Atlas dataset, which is accessible and contains many diverse experiments. AVAILABILITY AND IMPLEMENTATION: All data and processing scripts are available at this GitLab repository: https://gitlab.com/polavieja_lab/ml_multi-omics_review/ or in Zenodo: https://doi.org/10.5281/zenodo.7361807. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

MultiomicsNeoplasmsGenomeHumansMachine Learning

Identifiers

PMID36637211
PMCPMC9907220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.